title: Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives.
abstract: Protein C, protein S and antithrombin III were evaluated in normal pregnancy, severe preeclampsia and chronic hypertension with superimposed severe preeclampsia. The same study was performed on a group of 10 normal women using oral contraceptives. In normal pregnancy a significant decrease in the level of free and total PS was observed in the 2nd trimester of pregnancy and was sustained throughout the remaining months. No significant changes in the levels of protein C and antithrombin III were observed during normal pregnancy. In preeclamptic states a significant decrease in protein C was observed. It was more evident in severe preeclampsia when compared with the normal pregnancy group at similar gestational age. No statistically significant differences in protein S were found when the normal and pathological groups were compared. Antithrombin III decreased only slightly in the severe preeclamptic group. The decrease in protein C and antithrombin III levels in severe preeclampsia could be related with the microthrombotic state that these patients may present. However, the role played by protein S, which decreases during normal pregnancy and in preeclampsia, is not clear. A decrease in the level of total protein S was observed in the group of women using oral contraceptives. No significant changes in protein C and antithrombin III levels were observed in this group.
authors.affiliation: Department of Obstetrics and Gynecology, Hospital La Fe, Valencia, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Gilabert
authors.forename: J A
authors.initials: JA
authors.lastname: Fernandez
authors.forename: F
authors.initials: F
authors.lastname: España
authors.forename: J
authors.initials: J
authors.lastname: Aznar
authors.forename: A
authors.initials: A
authors.lastname: Estelles
mesh_terms: D000328:Adult; D000990:Antithrombin III / Q000378:metabolism*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D006023:Glycoproteins / Q000378:metabolism*; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000150:complications; D011225:Pre-Eclampsia / Q000097:blood* / Q000150:complications; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000097:blood; D011486:Protein C / Q000378:metabolism*; D017293:Protein S
chemical_list: D003276:Contraceptives, Oral; D006023:Glycoproteins; D011486:Protein C; D017293:Protein S; D000990:Antithrombin III